Detection of decreased susceptibility to fluoroquinolones in Salmonella spp. by five different methods including real-time polymerase chain reaction (PCR)

International Journal of Antimicrobial Agents

Volumn 30, Issue 1, 2007, Pages 67-71

  Aznar, E ^a   Alarcon, T ^a   Buendia B ^a   Garcia Penuela E ^a   Lopez Brea M ^a  

^a HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

Author keywords

Decreased susceptibility; Fluoroquinolones; Real time PCR; Salmonella

Indexed keywords

CIPROFLOXACIN; NALIDIXIC ACID; QUINOLONE DERIVATIVE;

AGAR GEL DIFFUSION; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; CONTROLLED STUDY; DILUTION; DNA SEQUENCE; GENE MUTATION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SALMONELLA; TEMPERATURE MEASUREMENT;

ANTI-BACTERIAL AGENTS; DNA GYRASE; DNA, BACTERIAL; DRUG RESISTANCE, BACTERIAL; FLUOROQUINOLONES; HUMANS; MICROBIAL SENSITIVITY TESTS; MUTATION; POLYMERASE CHAIN REACTION; SALMONELLA; TRANSITION TEMPERATURE;

EID: 34249879844     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2007.01.018     Document Type: Article

References (13)

1. Escribano I., Rodriguez J.C., and Royo G. Mutations in the gyrA gene in Salmonella enterica clinical isolates with decreased ciprofloxacin susceptibility. Int J Antimicrob Agents 24 (2004) 300-303
2. Hakanen A.J., Kotilainen P., Pitkänen S., Huikko S., Siitonen A., and Huovinen P. Reduction in fluoroquinolone susceptibility among non-typhoidal strains of Salmonella enterica isolated from Finnish patients. J Antimicrob Chemother 57 (2006) 569-572
3. Aarestrup F.M., Wiuff C., Molbak K., and Threlfall E.J. Is it time to change fluoroquinolone breakpoints for Salmonella spp.?. Antimicrob Agents Chemother 47 (2003) 827-829
4. Ruiz J., Castro D., Goni P., Santamaria J.A., Borrego J.J., and Vila J. Analysis of the mechanism of quinolone resistance in nalidixic acid-resistant clinical isolates of Salmonella serotype Typhimurium. J Med Microbiol 46 (1997) 623-628
5. Soto S.M., Ruiz J., and Vila J. In vitro fluoroquinolone-resistant mutants of Salmonella enterica serotype Enteritidis: analysis of mechanisms involved in resistance. Int J Antimicrob Agents 22 (2003) 537-540
6. Giraud E., Brisabois A., Martel J.L., and Chaslus-Dancla E. Comparative studies of mutations in animal isolates and experimental in vitro- and in vivo-selected mutants of Salmonella spp. suggest a counterselection of highly fluoroquinolone-resistant strains in the field. Antimicrob Agents Chemother 43 (1999) 2131-2137
7. Walker R.A., Skinner J.A., Ward L.R., and Threlfall E.J. LightCycler gyrA mutation assay (GAMA) identifies heterogeneity in GyrA in Salmonella enterica serotypes Typhi and Paratyphi A with decreased susceptibility to ciprofloxacin. Int J Antimicrob Agents 22 (2003) 622-625
8. Piddock L.J.V. Mechanisms of fluoroquinolone resistance: an update. Drugs 58 (1999) 11-18
9. Hakanen A., Kotilainen P., Jalava J., Siitonen A., and Huovinen P. Detection of decreased fluoroquinolone susceptibility in salmonellas and validation of nalidixic acid screening test. J Clin Microbiol 37 (1999) 3572-3577
10. Poutanen S., and Low D.E. Is it time to change fluoroquinolone MIC breakpoints for Salmonella spp.?. Clin Microbiol Newslett 25 (2003) 97-102
11. Steward C.D., Stocker S.A., and Swenson J.M. Comparison of agar dilution, disk diffusion, MicroScan, and Vitek antimicrobial susceptibility testing methods to broth microdilution for detection of fluoroquinolone-resistant isolates of the family Enterobacteriaceae. J Clin Microbiol 37 (1999) 544-547
12. Walker R.A., Saunders N., Lawson A.J., et al. Use of a LightCycler gyrA mutation assay for rapid identification of mutations conferring decreased susceptibility to ciprofloxacin in multiresistant Salmonella enterica serotype Typhimurium DT104 isolates. J Clin Microbiol 39 (2001) 1443-1448
13. Eaves D.J., Randall L., Gray D.T., et al. Prevalence of mutations within the quinolone resistance-determining region of gyrA, gyrB, parC, and parE and association with antibiotic resistance in quinolone-resistant Salmonella enterica. Antimicrob Agents Chemother 48 (2004) 4012-4015